Solid Biosciences's total assets for Q4 2024 were $188.66M, a decrease of -10.94% from the previous quarter. SLDB total liabilities were $51.42M for the fiscal quarter, a 14.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.